Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity
Molecular Diversity · 2025-08 · 29 (4) · 3575-3586
DOI: 10.1007/s11030-025-11203-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, online erschienen am 22.04.2025. Verfasst von Maryam Gholami und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Babol Noshirvani University of Technology, Babol, 47148-71167, Mazandaran, Iran. Hauptthemen laut MEDLINE: Antimalarials, Machine Learning, Plasmodium falciparum, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Malaria is a significant global health challenge, causing high morbidity and mortality. The rise of drug resistance highlights the urgent need for new antimalarial agents. This study focuses on predictive modeling of 104 Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors, employing a range of machine learning techniques to develop ensemble regression and classification models. Molecular descriptors were refined using classification and regression trees (CART) to identify the most relevant features. Six machine learning algorithms (Random Forest (RF), Relevance Vector Machine (RVM), Support Vector Machine (SVM), Cubist, Artificial Neural Networks (ANN), and XGBoost) were utilized to construct regression models. The consensus model demonstrated superior predictive performance, achieving R2Test = 0.94, SETest = 0.20, Q2CV = 0.90, and SECV = 0.25, outperforming individual models. For classification tasks, five algorithms were evaluated and a majority voting approach yielded an accuracy of 91% and a sensitivity of 93%. The robustness of the models was confirmed through applicability domain analysis (96% coverage) and y-randomization tests, ensuring that the predictive outcomes were not due to chance correlations. This study highlights the effectiveness of ensemble machine learning approaches in predictive modeling and provides critical insights for the rational design of novel PfPK6 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Babol Noshirvani University of Technology, Babol, 47148-71167, Mazandaran, Iran.
- Department of Chemistry, Faculty of Science, Babol Noshirvani University of Technology, Babol, 47148-71167, Mazandaran, Iran. asadollahi@nit.ac.ir.
Zitieren
APA
Gholami, M., & Asadollahi-Baboli, M. (2025). Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity. Molecular Diversity, 29(4), 3575-3586. https://doi.org/10.1007/s11030-025-11203-9
Vancouver
Gholami M, Asadollahi-Baboli M. Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity. Molecular Diversity. 2025;29(4):3575-3586. doi:10.1007/s11030-025-11203-9
BibTeX
@article{Gholami2025,
author = {Gholami, Maryam and Asadollahi-Baboli, Mohammad},
title = {Advancing antimalarial drug discovery: ensemble machine learning models for predicting PfPK6 inhibitor activity},
journal = {Molecular Diversity},
year = {2025},
volume = {29},
number = {4},
pages = {3575--3586},
doi = {10.1007/s11030-025-11203-9}
}
EUVIMED